Global Cancer Profiling Market to Reach USD 16.0 Billion by 2027
The global cancer profiling market is undergoing rapid transformation, powered by breakthroughs in genomics, biomarker discovery, and precision oncology. Valued at USD 9.7 billion in 2022 , the market is projected to reach USD 16.0 billion by 2027 , growing at a compound annual growth rate (CAGR) of 10.6% during the forecast period. This remarkable growth reflects the rising investment in cancer research, increasing adoption of advanced molecular diagnostics, and a global shift toward personalized medicine —a treatment approach tailored to an individual’s genetic makeup. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202 🌎 Market Overview Cancer profiling, also known as tumor profiling , involves the analysis of genetic, epigenetic, and proteomic alterations in cancer cells. It helps clinicians identify specific biomarkers that drive tumor growth and predict a patient’s response to targeted therapies. According to recent market insi...